SCHEMBL21360283

SCHEMBL21360283

CC(=O)NC(Cc1ccccc1)C(=O)NC(C=O)CCCNC(=N)N

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GNPAT O15228 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ CTSK P43235 4/20 0.49
▸ CTSS P25774 1/20 0.49
▸ KISS1R Q969F8 1/20 0.47
▸ NPY4R P50391 6/20 0.45
▸ NPY1R P25929 4/20 0.45
▸ NPY2R P49146 3/20 0.45
▸ NPY5R Q15761 3/20 0.45
▸ PTPN2 P17706 1/20 0.45
▸ PTPN1 P18031 1/20 0.45
▸ GRIA1 P42261 1/20 0.44
▸ CTSL P07711 1/20 0.44
▸ CTSB P07858 1/20 0.44
▸ CTSH P09668 1/20 0.44
▸ F2 P00734 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24178268 0.92 FNTA (0.47) GNPATSMN1; SMN2KISS1RNPY4RNPY1R
SCHEMBL21167756 0.91 F2 (0.50) SMN1; SMN2CTSKNPY4RNPY1RNPY2R
SCHEMBL7368582 0.90 GNPAT (0.48) GNPATSMN1; SMN2KISS1RNPY4RNPY1R
SCHEMBL24736900 0.87 CTSC (0.45) SMN1; SMN2CTSKNPY4RNPY1RNPY2R
SCHEMBL3134717 0.87 CTSC (0.45) SMN1; SMN2CTSKNPY4RNPY1RNPY2R
SCHEMBL30533200 0.86 GNPAT (0.70) GNPATCTSKCTSSKISS1RNPY4R
SCHEMBL11569736 0.86 GNPAT (0.70) GNPATCTSKCTSSKISS1RNPY4R
SCHEMBL11294449 0.86 GNPAT (0.70) GNPATCTSKCTSSKISS1RNPY4R
SCHEMBL7373235 0.86 CTSS (0.53) CTSKCTSSPTPN1CTSLCTSB
SCHEMBL12792618 0.85 KISS1R (0.62) GNPATKISS1RNPY4RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10414796-B2 Genetic system for producing a proteases inhibitor of a small peptide aldehyde type CENTRO DE INVESTIGACIÓN Y DE ESTUDIOS AVANZADOS DEL INSTITUTO POLITÉCNICO NACIONAL (MX) 2019-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10414796-B2 Genetic system for producing a proteases inhibitor of a small peptide aldehyde type SPPL2A, SPPL2B, HM13 GNPAT 78/4885SMN1; SMN2 4293/4885CTSK 545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback